These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 6320148)

  • 1. Post-menopausal osteoporosis and estrogens. Who should be treated and why.
    Saville PD
    Postgrad Med; 1984 Feb; 75(2):135-8, 142-3. PubMed ID: 6320148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biologic effects of various doses of ethinyl estradiol in postmenopausal women.
    Mandel FP; Geola FL; Lu JK; Eggena P; Sambhi MP; Hershman JM; Judd HL
    Obstet Gynecol; 1982 Jun; 59(6):673-9. PubMed ID: 6281707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term estrogen replacement therapy prevents bone loss and fractures.
    Ettinger B; Genant HK; Cann CE
    Ann Intern Med; 1985 Mar; 102(3):319-24. PubMed ID: 2982302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced vaginal bleeding in postmenopausal women who receive combined norethindrone acetate and low-dose ethinyl estradiol therapy versus combined conjugated equine estrogens and medroxyprogesterone acetate therapy.
    Simon JA; Liu JH; Speroff L; Shumel BS; Symons JP
    Am J Obstet Gynecol; 2003 Jan; 188(1):92-9. PubMed ID: 12548201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of osteoporosis: treatment of estradiol deficiency.
    Ettinger B
    Obstet Gynecol; 1988 Nov; 72(5 Suppl):12S-17S. PubMed ID: 3173936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of estrogen on calcium absorption and serum vitamin D metabolites in postmenopausal osteoporosis.
    Gallagher JC; Riggs BL; DeLuca HF
    J Clin Endocrinol Metab; 1980 Dec; 51(6):1359-64. PubMed ID: 6255005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Basic principles of hormone replacement therapy in the postmenopause].
    Dören M
    Ther Umsch; 2000 Oct; 57(10):628-34. PubMed ID: 11081374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The evolving role of oral hormonal therapies and review of conjugated estrogens/bazedoxifene for the management of menopausal symptoms.
    Parish SJ; Gillespie JA
    Postgrad Med; 2017 Apr; 129(3):340-351. PubMed ID: 28132583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrogens for the menopause. Maximizing benefits, minimizing risks.
    Seller JC
    Postgrad Med; 1977 Sep; 62(3):73-9. PubMed ID: 197509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bazedoxifene/conjugated estrogens for menopausal symptom treatment and osteoporosis prevention.
    Pinkerton JV; Pickar JH; Racketa J; Mirkin S
    Climacteric; 2012 Oct; 15(5):411-8. PubMed ID: 22853444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short- and long-term effects of estrogen and synthetic anabolic hormone in postmenopausal osteoporosis.
    Riggs BL; Jowsey J; Goldsmith RS; Kelly PJ; Hoffman DL; Arnaud CD
    J Clin Invest; 1972 Jul; 51(7):1659-63. PubMed ID: 4338118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcitonin and the calcium-regulating hormones in postmenopausal women: effect of oestrogens.
    Stevenson JC; Abeyasekera G; Hillyard CJ; Phang KG; MacIntyre I; Campbell S; Townsend PT; Young O; Whitehead MI
    Lancet; 1981 Mar; 1(8222):693-5. PubMed ID: 6110915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transdermal estradiol in the treatment of postmenopausal bone loss.
    Adami S; Suppi R; Bertoldo F; Rossini M; Residori M; Maresca V; Lo Cascio V
    Bone Miner; 1989 Aug; 7(1):79-86. PubMed ID: 2670019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Estrogen metabolism and hormone substitution in the climacteric].
    Göretzlehner G; Kyank H
    Zentralbl Gynakol; 1985; 107(16):977-88. PubMed ID: 2996259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 17 beta-estradiol for postmenopausal estrogen replacement therapy.
    Nichols KC; Schenkel L; Benson H
    Obstet Gynecol Surv; 1984 Apr; 39(4):230-45. PubMed ID: 6717863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postmenopausal osteoporosis and hormone replacement therapy.
    Gambacciani M; Vacca F
    Minerva Med; 2004 Dec; 95(6):507-20. PubMed ID: 15785435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hormone replacement therapy: optimising the dose and route of administration.
    Montgomery Rice V
    Drugs Aging; 2002; 19(11):807-18. PubMed ID: 12428992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone turnover-sex hormone-parathyroid hormone interrelationships in postmenopausal osteoporosis.
    Riggs B; Jowsey J; Kelly PJ; Arnaud CD
    Boll Soc Ital Biol Sper; 1973 Jul; 49(12):732-7. PubMed ID: 4364781
    [No Abstract]   [Full Text] [Related]  

  • 19. Optimizing the dose of hormone replacement therapy.
    Rice VM
    Int J Fertil Womens Med; 2002; 47(5):205-10. PubMed ID: 12469707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparison of the osteoprotective effects of orally administered equine conjugated estrogens and percutaneous 17 beta-estradiol].
    Reginster JY; Sarlet N; Deroisy R; Denis D; Lecart MP; Franchimont P
    Rev Med Liege; 1989 Jan; 44(2):55-60. PubMed ID: 2538905
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.